FIELD: medicine.
SUBSTANCE: method involves applying organic selenium compound like 9-phenyl-symmetric-octahydroselenium xanthene as hematopoietic precursor cell differentiation inhibitor.
EFFECT: enhanced effectiveness of irradiation and cytostatic agents application; reduced harmful action; improved normal tissue protection.
10 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTING INJURIOUS ENVIRONMENTAL EFFECTS | 2002 |
|
RU2234918C2 |
| METHOD FOR ASSESSING PERSONIFIED RADIOSENSITIVITY OF PERSON BASED ON DETERMINING RESPONSE OF HIS HAEMOPOIETIC STEM CELLS TO RADIATION EXPOSURE USING HUMANIZED MICE | 2022 |
|
RU2817984C1 |
| METHOD OF PROTECTING ANIMALS FROM HIGH-DOSE IONIZING RADIATION | 2019 |
|
RU2701155C1 |
| METHOD FOR TREATING DISEASES | 2006 |
|
RU2322264C1 |
| METHOD FOR EVALUATING EFFICACY OF RADIOPROTECTIVE DRUGS USING HUMANISED MICE | 2023 |
|
RU2817986C1 |
| AGENT STIMULATING ERYTHROPOIESIS | 1985 |
|
RU2061496C1 |
| MEDICATION OF STIMULATION OF STEM CELL PRODUCTION IN BONE MARROW | 2007 |
|
RU2410116C2 |
| METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
| AGENT POSSESSING SELECTIVE RADIO- AND CHEMOPROTECTIVE ACTION | 2007 |
|
RU2339386C1 |
| PEPTIDE HAVING EFFECT ON REGENERATION OF HOMOGENIC AND IMMUNE SYSTEMS, AND PHARMACEUTICAL COMPOSITION BASED THEREON | 1996 |
|
RU2121480C1 |
